StockData
Biohaven Ltd. logo

Biohaven Ltd. (BHVN) stock

BHVNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 1/30
$13.24−0.56 (-4.06%)

Close on Nov 17, 2026Market cap $2.00BP/E –Yield –

Biohaven enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Biohaven's enterprise value was $2.29B on Nov 11, 2026, against $1.07B a year earlier. Over the last 5 years it ranged from -$50.67M to $5.52B, with a median of $2.13B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.29B+90.1%
2025Dec 31, 2025$1.20B-62.0%
2024Dec 31, 2024$3.17B+17.9%
2023Dec 29, 2023$2.69B–
2022Dec 30, 2022-$50.67M-100.9%
2021Dec 31, 2021$5.34B–

More Biohaven figures

See a number that looks wrong?